Chronic Kidney Disease Trial, Recruiting (NCT07237295)

Chronic Kidney Disease Trial, Recruiting NCT07237295 Sponsor: University of North Carolina, Chapel Hill Condition: Chronic Kidney Disease

Printed from Voxsanity (voxsanity.com.au) — NCT07237295 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Chronic Kidney Disease

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who have been diagnosed with chronic kidney disease (a long-term condition where the kidneys do not work as well as they should), but not at the most advanced stage (end-stage kidney disease), based on medical records or certain lab results showing reduced kidney function or protein in the urine
People who have had at least one appointment at Goshen Medical Center in the 12 months before joining the trial

Who may not be able to join:

People who have a serious illness that significantly shortens life expectancy, such as advanced cancer, severe liver disease, or those receiving end-of-life (hospice) care
People who are currently receiving treatment for cancer
People who live full-time in a skilled nursing facility (a residential care facility with round-the-clock nursing support)
People who have dementia or another condition that significantly affects memory or thinking, or who are unable to go through the process of understanding and agreeing to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 13 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Gaurav J Dave, MBBS, MPH, DrPH, University of North Carolina, Chapel Hill

Phone: 910-939-1879

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07237295

Sponsor: University of North Carolina, Chapel Hill

Phase: Not Applicable

Status: Recruiting

Condition: Chronic Kidney Disease

Trial contact: 910-939-1879

More information: https://clinicaltrials.gov/study/NCT07237295

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who have been diagnosed with chronic kidney disease (a long-term condition where the kidneys do not work as well as they should), but not at the most advanced stage (end-stage kidney disease), based on medical records or certain lab results showing reduced kidney function or protein in the urine
People who have had at least one appointment at Goshen Medical Center in the 12 months before joining the trial

Who may not be able to join:

People who have a serious illness that significantly shortens life expectancy, such as advanced cancer, severe liver disease, or those receiving end-of-life (hospice) care
People who are currently receiving treatment for cancer
People who live full-time in a skilled nursing facility (a residential care facility with round-the-clock nursing support)
People who have dementia or another condition that significantly affects memory or thinking, or who are unable to go through the process of understanding and agreeing to take part in the trial

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 13 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of North Carolina, Chapel Hill

Registry

ClinicalTrials.gov

Start date

13 April 2026

Est. completion

1 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Acute healthcare utilization

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 13 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov